← Back to MGNX

MacroGenics, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 14/08/2026Mar 2026Filed 14/08/2026Sep 2025Filed 12/11/2025Jun 2025Filed 14/08/2026Mar 2025Filed 14/08/2026Sep 2024Filed 12/11/2025Jun 2024Filed 12/11/2025Mar 2024Filed 12/11/2025
$33$21$73$6.9$13$111$11$9.1
$20−$37$17−$36−$41$56−$56−$52
$0.31−$0.58$0.27−$0.57−$0.65$0.90−$0.89−$0.84
6463636363636362

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.